153 Followers on Owler
Rein is a Texas-based biopharmaceutical company that discovers and develops novel therapies for treating patients with orphan pulmonary and fibrosis indications... Read more
OverviewAcquisitionsFundingNews & Insights
Rein is a Texas-based biopharmaceutical company that discovers and develops novel therapies for treating patients with orphan pulmonary and fibrosis indications... Read more
Rein Therapeutics President & CEO: Brian Windsor

President & CEO

Brian Windsor

CEO Approval Rating

90/100

2001

PublicIndependent CompanyNASDAQRNTX

Pharmaceuticals & Biotechnology
BiotechnologyPharmaceuticals

Annual Revenue
<$1M
Employees
9
Funding
$257.4M
Acquisitions
1

News

Rebranding
Jan 10, 2025
Marketscreener
Aileron Therapeutics Announces Rebranding to Rein Therapeutics
Funding
May 02, 2024
benzinga.com
Rein Therapeutics received $20M in Post-IPO Equity Funding